Cutaneous Leishmaniasis. Cutaneous Leishmaniasis
Conditions
Interventions
Cleansing of location by isopropyl alcohol 70%, and then dressing is performed for local anesthesia. After 45 minutes, the location is washed and dried. Treatment will be performed with laser beam siz
Treatment - Devices
Sponsors
Mashhad University of Medical Sciences, Vice Chancellor for Research
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age more than 12 years old; informed consent of patient for participating in study; atrophic scar in hand or face with duration of improvement more than one year Exclusion criteria: patients with chronic disease like diabetes and collagen vascular diseases that have a problem in scar healing; hypertrophic or keloid scars; history for receiving isotretinoin during last year; pregnancy or breastfeeding; immunodeficiency patients like patients under immunosuppressive medicines; patients who don’t complete treatment period or don’t refer for follow ups; skin type VI; history of radiotherapy in laser locations; patients with positive coiner disease like psoriasis and vitiligo
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete healing. Timepoint: For the first before intervention, then during therapy sessions, and 3 and 6 months after the last treatment session. Method of measurement: Measuring the size of induration and scar. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects including erythema, edema, petechiae, dispigmentation and scar. Timepoint: start of therapy, 3 and 6 months after the last treatment session. Method of measurement: Physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hamid Reza Moghimi
Mashhad University of Medical Sciences
Outcome results
None listed